statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adagene Inc. (NASDAQ:ADAG - Get Free Report) was the recipient of a large growth in short interest in March. As of March 15th, there was short interest totalling 22,300 shares, a growth of 9.9% from...

Adagene Inc. (NASDAQ:ADAG) Short Interest Update

For the last three days, A.I.dvisor has detected that ADAG's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Adagene (ADAG, $3.24) Aroon Indicator entered a Downtrend on April 01, 2024.

Adagene Inc. (NASDAQ:ADAG - Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 22,300 shares, an...

Adagene ( NASDAQ:ADAG ) Full Year 2023 Results Key Financial Results Revenue: US$10.2m (up 9.5% from FY 2022). Net...

Adagene Full Year 2023 Earnings: US$1.83 loss per share (vs US$1.85 loss in FY 2022)

Adagene, Inc. (ADAG) has released an update. Adagene Inc. has entered into a sales agreement with Leerink Partners LLC to issue and sell American D...

Adagene Inc. Strikes Deal to Sell Depositary Shares

Adagene ADR Non-GAAP EPS of -$0.21, revenue of $18.11M...

Adagene ADR Non-GAAP EPS of -$0.21, revenue of $18.11M

Adagene, Inc. (ADAG) has released an update. Adagene Inc.'s 2023 financial report reveals a successful year with a cash balance that supports opera...

Adagene's Breakthroughs Promise Future Growth

- Data for masked anti-CTLA-4 SAFEbody ADG126 (muzastotug) highlight best-in-class therapeutic index and demonstrate clinical benefits in metastatic microsatellite-stable (MSS) colorectal cancer...

Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update

Shares of Adagene Inc. (NASDAQ:ADAG  Get Free Report) were down 8.4% during trading on Thursday . The stock traded as low as $2.55 and last traded at $2.61. Approximately 13,978 shares were...

Adagene (NASDAQ:ADAG)  Shares Down 8.4%

- Global oncology expert brings deep insight in colorectal cancer and role of CTLA-4 therapy as a cornerstone for combination immunotherapy - SAN DIEGO and SUZHOU, China, March 07, 2024 (GLOBE...

Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Watchers	155
52-Wk Low	$1.10
52-Wk High	$4.38

Volume	25,734.00
52-Wk High	$4.38
52-Wk Low	$1.10

ADAG Adagene Inc - ADR

About

Feed

News

Sentiment

Fundamentals